HealthEquity (HQY) r&d spend was $263M in FY2026 (+10% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2026
$263M
+10%
2025
$240M
+9%
2024
$219M
+13%
2023
$193M
+23%
2022
$157M
+26%
2021
$125M
+61%
2020
$78M
+121%
2019
$35M
+28%
2018
$27M
+22%
2017
$22M
+33%
2016
$17M
+60%
2015
$11M
+47%
2014
$7M
+69%
2013
$4M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$74M
Q1 2026
$68M
Q3 2025
$66M
Q2 2025
$65M
Q1 2025
$61M
Q3 2024
$60M
Q2 2024
$59M
Q1 2024
$56M
Q3 2023
$56M
Q2 2023
$55M
Q1 2023
$53M
Q3 2022
$49M
Source: HQY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.